drugset / Trial / NCT01441284

Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor

NCT01441284

Phase 3 Withdrawn University of Pecs
RandomizedCrossoverQuadruple-blindTreatment

Summary

Aim of the study is to perform a double-blind, crossover, placebo-controlled multicenter study evaluating the efficacy of pramipexole on essential tremor.

Timeline

Start
2017-12
Primary completion
2018-12
Completion
2018-12

Publications

  • Background Kovács N, Pál E, Késmárky I, Komoly S, Nagy F, Herceg M. Pramipexole for treating essential tremor. Eur J Neurol 2011;18(Suppl 2):482.

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pramipexole Unknown 2.1 mg

Indications